DMK PHARMACEUTICALS CORPORATION Proceeds from Other Equity
DMK PHARMACEUTICALS CORPORATION reported Proceeds from Other Equity of $8.01 million for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-14.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromOtherEquity · last filed 2023-11-14
- DMK PHARMACEUTICALS CORPORATION proceeds from other equity for the quarter ending 2023-03-31 was $899.39K.
| Period end | Proceeds from Other Equity 3 month | Proceeds from Other Equity 9 month |
|---|---|---|
| 2023-09-30 | $8.01M 10-Q · filed 2023-11-14 | |
| 2023-03-31 | $899.39K 10-Q · filed 2023-05-15 |